Reprieve Cardiovascular
Latest round
- Series B
Last raised
- May 2025
Total raised
- $58M
Investors
- 7
About Reprieve Cardiovascular
Reprieve Cardiovascular, Inc.Founded in 2018, Reprieve Cardiovascular, Inc. focuses on developing innovative solutions for heart failure management. In August 2025, Reprieve Cardiovascular, Inc.Reprieve Cardiovascular primarily offers an innovative automated fluid management technology designed to enhance the treatment of Acute Heart Failure (HF) patients. Their core product, the Reprieve System, integrates real-time patient data with established medical practices to optimize diuretic management. This technology provides physicians and care teams with comprehensive visibility and control over treatment protocols, aimed at addressing the urgent need for precise fluid management in heart failure patients. The system is tailored for use in clinical settings across the United States, where healthcare professionals navigate the complexities of diuretic administration to prevent complications such as kidney injury while ensuring effective fluid removal.Reprieve Cardiovascular generates revenue primarily through partnerships with healthcare institutions and potential subscription models for the use of their Reprieve System. The company’s transaction structure involves direct agreements with hospitals and healthcare systems that wish to implement their fluid management technology. These agreements encompass initial setup costs and ongoing fees associated with the use of the Reprieve System, including maintenance and software updates. Specific pricing details have not been disclosed, but the company aims to establish a sustainable revenue stream through direct engagement with healthcare providers committed to improving heart failure management. As the Reprieve System is still in investigational use, further developments in revenue structures are anticipated as the technology progresses toward wider implementation.
Who invested in Reprieve Cardiovascular
7 investors across 3 rounds
See all investors in Reprieve Cardiovascular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Reprieve Cardiovascular
Who invested in Reprieve Cardiovascular?
Reprieve Cardiovascular has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Reprieve Cardiovascular raised?
Reprieve Cardiovascular has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Reprieve Cardiovascular last raise money?
Reprieve Cardiovascular's most recent round on record is a Series B, in May 2025.
What does Reprieve Cardiovascular do?
Reprieve Cardiovascular is a medical devices & equipment company.
Where is Reprieve Cardiovascular headquartered?
Reprieve Cardiovascular is headquartered in US.
Which VCs invest in companies like Reprieve Cardiovascular?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Reprieve Cardiovascular's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Reprieve Cardiovascular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.